These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 2143030)

  • 1. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
    Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
    J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
    Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
    Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimate of relative function and transit time in renographic studies.
    González A; Ros D; Pavia J
    J Nucl Biol Med (1991); 1994 Sep; 38(3):502-7. PubMed ID: 7865547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of renal function using MAG3.
    Russell CD; Dubovsky EV
    J Nucl Med; 1991 Nov; 32(11):2061-3. PubMed ID: 1834813
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitation of renal function with technetium-99m MAG3.
    Russell CD; Thorstad BL; Yester MV; Stutzman M; Dubovsky EV
    J Nucl Med; 1988 Dec; 29(12):1931-3. PubMed ID: 2973517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of renal transplant survival from early postoperative radioisotope studies.
    Russell CD; Yang H; Gaston RS; Hudson SL; Diethelm AG; Dubovsky EV
    J Nucl Med; 2000 Aug; 41(8):1332-6. PubMed ID: 10945523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
    Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
    Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
    Bagni B; Portaluppi F; Montanari L; Prandini N; Zatta G
    J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
    Stabin M; Taylor A; Eshima D; Wooter W
    J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents.
    Eshima D; Taylor A; Fritzberg AR; Kasina S; Hansen L; Sorenson JF
    J Nucl Med; 1987 Jul; 28(7):1180-6. PubMed ID: 2955085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
    Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
    Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimum sample times for single-injection, multisample renal clearance methods.
    Russell CD
    J Nucl Med; 1993 Oct; 34(10):1761-5. PubMed ID: 8410295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
    Eshima D; Taylor A
    Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
    Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
    J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The difference in clearance between kit-prepared technetium-99m-MAG3 and radioiodinated hippuric acid.
    Bubeck B; Brandau W
    J Nucl Med; 1991 Aug; 32(8):1642-4. PubMed ID: 1831230
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of technetium-99m MAG3 with iodine-131 hippuran by a simultaneous dual channel technique.
    Russell CD; Thorstad B; Yester MV; Stutzman M; Baker T; Dubovsky EV
    J Nucl Med; 1988 Jul; 29(7):1189-93. PubMed ID: 2969040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of renal function using 99mTc-MAG3 comparison with 131I-OIH by simultaneous dual energy peak acquisition method].
    Hashimoto T; Matsumoto K; Ishibashi R; Iwasaki R; Sanmiya T; Hashimoto J; Kunieda E; Nakamura K; Kubo A
    Kaku Igaku; 1995 Feb; 32(2):139-46. PubMed ID: 7715099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
    Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L
    Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.